Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents may be viewed at URL.
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 14-21 October 2008.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents; 1: INTRODUCTION TO DOSING MEDICATIONS IN OBESE PATIENTS; 2: ANTIMICROBIAL DOSING IN OBESITY; 3: ANTICOAGULANTS AND ANTIPLATELETS; 4: CRITICAL CARE; 5: ANTIEPILEPTICS; 6: DOSING ANTINEOPLASTIC MEDICATIONS IN OBESE PATIENTS; 7: PEDIATRICS; 8: IMMUNOSUPPRESSION DOSING IN OBESE SOLID…
c.1 BC Cancer Agency VAN Library REF | Available | ||
c.1 BC Cancer Agency ARHCC Library REF | Available | ||
c.1 BC Cancer Agency VIC Library REF | Available |
Version 4.0 published: May 28, 2009 (v4.03: June14, 2010)."
Volume 1: A-L; Volume 2: M-Z
v.1 BC Cancer Agency VAN Library | Available | ||
v.2 BC Cancer Agency VAN Library | Available |
Volume 1: A-L; Volume 2: M-Z
v.1 BC Cancer Agency VAN Library REF | Available | ||
v.2 BC Cancer Agency VAN Library REF | Available |
This publication represents the views and expert; opinions of an IARC Working Group on the; Evaluation of Carcinogenic Risks to Humans which met in Lyon , 30 September - 7 October 2014.
c.1 BC Cancer Agency VAN Library | Available |